Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tandem Diabetes Care (TNDM) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Tandem Diabetes Care (TNDM) over the last 13 years, with Q3 2025 value amounting to $157.2 million.

  • Tandem Diabetes Care's Operating Expenses rose 425.15% to $157.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $732.1 million, marking a year-over-year increase of 3096.89%. This contributed to the annual value of $588.7 million for FY2024, which is 203.34% down from last year.
  • Per Tandem Diabetes Care's latest filing, its Operating Expenses stood at $157.2 million for Q3 2025, which was up 425.15% from $177.7 million recorded in Q2 2025.
  • Over the past 5 years, Tandem Diabetes Care's Operating Expenses peaked at $239.3 million during Q1 2025, and registered a low of $76.5 million during Q1 2021.
  • Moreover, its 5-year median value for Operating Expenses was $136.4 million (2024), whereas its average is $138.1 million.
  • Its Operating Expenses has fluctuated over the past 5 years, first surged by 9799.12% in 2023, then tumbled by 3529.45% in 2024.
  • Over the past 5 years, Tandem Diabetes Care's Operating Expenses (Quarter) stood at $101.0 million in 2021, then surged by 31.99% to $133.3 million in 2022, then dropped by 3.71% to $128.4 million in 2023, then rose by 23.12% to $158.0 million in 2024, then decreased by 0.56% to $157.2 million in 2025.
  • Its last three reported values are $157.2 million in Q3 2025, $177.7 million for Q2 2025, and $239.3 million during Q1 2025.